Cargando…

Molecular Mechanisms of Epigallocatechin-3-Gallate for Prevention of Chronic Kidney Disease and Renal Fibrosis: Preclinical Evidence

Chronic kidney disease (CKD) is a common public health problem worldwide characterized by gradual decline of renal function over months/years accompanied by renal fibrosis and failure in tissue wound healing after sustained injury. Patients with CKD frequently present with profound signs/symptoms th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kanlaya, Rattiyaporn, Thongboonkerd, Visith
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6752729/ https://www.ncbi.nlm.nih.gov/pubmed/31555758 http://dx.doi.org/10.1093/cdn/nzz101

Ejemplares similares

Protective effect of epigallocatechin-3-gallate (EGCG) via Nrf2 pathway against oxalate-induced epithelial mesenchymal transition (EMT) of renal tubular cells
por: Kanlaya, Rattiyaporn, et al.
Publicado: (2016)

Quantitative peptidomics of endogenous peptides involved in TGF-β1-induced epithelial mesenchymal transition of renal epithelial cells
por: Kanlaya, Rattiyaporn, et al.
Publicado: (2018)

Caffeine inhibits hypoxia-induced renal fibroblast activation by antioxidant mechanism
por: Nilnumkhum, Angkhana, et al.
Publicado: (2019)

Caffeine causes cell cycle arrest at G0/G1 and increases of ubiquitinated proteins, ATP and mitochondrial membrane potential in renal cells
por: Kanlaya, Rattiyaporn, et al.
Publicado: (2023)

Flagellum Is Responsible for Promoting Effects of Viable Escherichia coli on Calcium Oxalate Crystallization, Crystal Growth, and Crystal Aggregation
por: Kanlaya, Rattiyaporn, et al.
Publicado: (2019)

Roles of Macrophage Exosomes in Immune Response to Calcium Oxalate Monohydrate Crystals
por: Singhto, Nilubon, et al.
Publicado: (2018)

Cellular proteome datasets of human endothelial cells under physiologic state and after treatment with caffeine and epigallocatechin-3-gallate
por: Chanthick, Chanettee, et al.
Publicado: (2019)

Effects of secretome derived from macrophages exposed to calcium oxalate crystals on renal fibroblast activation
por: Yoodee, Sunisa, et al.
Publicado: (2021)

Caveolae-mediated albumin transcytosis is enhanced in dengue-infected human endothelial cells: A model of vascular leakage in dengue hemorrhagic fever
por: Chanthick, Chanettee, et al.
Publicado: (2016)

Differential proteomics of lesional vs. non-lesional biopsies revealed non-immune mechanisms of alopecia areata
por: Thanomkitti, Kanchalit, et al.
Publicado: (2018)

Preclinical Activities of Epigallocatechin Gallate in Signaling Pathways in Cancer
por: Sharifi-Rad, Mehdi, et al.
Publicado: (2020)

Kidney Stone Prevention
por: Peerapen, Paleerath, et al.
Publicado: (2023)

Anticancer effects and molecular mechanisms of epigallocatechin-3-gallate
por: Min, Kyoung-jin, et al.
Publicado: (2014)

Caffeine prevents kidney stone formation by translocation of apical surface annexin A1 crystal-binding protein into cytoplasm: In vitro evidence
por: Peerapen, Paleerath, et al.
Publicado: (2016)

Protein network analysis and functional enrichment via computational biotechnology unravel molecular and pathogenic mechanisms of kidney stone disease
por: Peerapen, Paleerath, et al.
Publicado: (2023)

Roles for Exosome in Various Kidney Diseases and Disorders
por: Thongboonkerd, Visith
Publicado: (2020)

StoneMod: a database for kidney stone modulatory proteins with experimental evidence
por: Sassanarakkit, Supatcha, et al.
Publicado: (2020)

Molecular Interactions between (−)-Epigallocatechin Gallate Analogs and Pancreatic Lipase
por: Wang, Shihui, et al.
Publicado: (2014)

Skin Protective Effect of Epigallocatechin Gallate
por: Kim, Eunji, et al.
Publicado: (2018)

Suppressive effect of epigallocatechin‐3‐O‐gallate on endoglin molecular regulation in myocardial fibrosis in vitro and in vivo
por: Lin, Chiu‐Mei, et al.
Publicado: (2016)

Role of Epigallocatechin Gallate in Glucose, Lipid, and Protein Metabolism and L-Theanine in the Metabolism-Regulatory Effects of Epigallocatechin Gallate
por: Lin, Ling, et al.
Publicado: (2021)

Proteomics of Crystal–Cell Interactions: A Model for Kidney Stone Research
por: Thongboonkerd, Visith
Publicado: (2019)

Mitochondrial Dysfunction and Kidney Stone Disease
por: Chaiyarit, Sakdithep, et al.
Publicado: (2020)

Calcium oxalate crystals trigger epithelial-mesenchymal transition and carcinogenic features in renal cells: a crossroad between kidney stone disease and renal cancer
por: Peerapen, Paleerath, et al.
Publicado: (2022)

(−)-Epigallocatechin-3-gallate Inhibits Human and Rat Renal Organic Anion Transporters
por: Kawasaki, Tatsuya, et al.
Publicado: (2021)

The roles of epigallocatechin-3-gallate in the treatment of neuropathic pain: an update on preclinical in vivo studies and future perspectives
por: Bimonte, Sabrina, et al.
Publicado: (2017)

Epigallocatechin Gallate Nanodelivery Systems for Cancer Therapy
por: Granja, Andreia, et al.
Publicado: (2016)

Food-Grade Encapsulation Systems for (−)-Epigallocatechin Gallate
por: Shi, Meng, et al.
Publicado: (2018)

Therapeutic Potential of Epigallocatechin Gallate Nanodelivery Systems
por: Granja, Andreia, et al.
Publicado: (2017)

Effect of Epigallocatechin Gallate on Viability of Kudoa septempunctata
por: Shin, Sang Phil, et al.
Publicado: (2020)

Effects of epigallocatechin-3-gallate combined with ascorbic acid and glycerol on the stability and uric acid-lowering activity of epigallocatechin-3-gallate
por: Xie, Qianjin, et al.
Publicado: (2021)

Calcium oxalate crystals increased enolase-1 secretion from renal tubular cells that subsequently enhanced crystal and monocyte invasion through renal interstitium
por: Chiangjong, Wararat, et al.
Publicado: (2016)

Current update on theranostic roles of cyclophilin A in kidney diseases
por: Hadpech, Sudarat, et al.
Publicado: (2022)

Mitochondria-derived vesicles and their potential roles in kidney stone disease
por: Chaiyarit, Sakdithep, et al.
Publicado: (2023)

The cytotoxic mechanism of epigallocatechin gallate on proliferative HaCaT keratinocytes
por: Chu, Yu-Wen, et al.
Publicado: (2017)

In Silico Investigation of the Anti-Tumor Mechanisms of Epigallocatechin-3-Gallate
por: Wang, Wang, et al.
Publicado: (2019)

Mechanism of (−)-epigallocatechin gallate (EGCG) dimerization by low-temperature plasma
por: Park, Seungil, et al.
Publicado: (2022)

Epigallocatechin-3 gallate prevents cardiac hypertrophy induced by pressure overload in rats
por: Hao, Jia, et al.
Publicado: (2007)

Epigallocatechin Gallate: A Review of Its Beneficial Properties to Prevent Metabolic Syndrome
por: Legeay, Samuel, et al.
Publicado: (2015)

Targeted nanoparticles encapsulating (−)-epigallocatechin-3-gallate for prostate cancer prevention and therapy
por: Sanna, Vanna, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_eevo4seup3l01827t53g4tik6t